Free Trial

Novozymes A/S (OTCMKTS:NVZMY) Share Price Crosses Above 50 Day Moving Average - What's Next?

Novozymes A/S logo with Basic Materials background

Key Points

  • Novozymes A/S's share price recently **crossed above** its fifty-day moving average of **$62.76**, reaching a high of **$64.55** before trading at **$63.00**.
  • Analysts have **downgraded** Novozymes A/S from a "strong-buy" to a "hold" rating, but the stock continues to have an average rating of **"Buy"**.
  • The company announced a **dividend** of **$0.1856** per share, reflecting a yield of **88.0%**, with a payout ratio of **23.42%**.
  • Five stocks to consider instead of Novozymes A/S.

Novozymes A/S (OTCMKTS:NVZMY - Get Free Report)'s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $62.76 and traded as high as $64.55. Novozymes A/S shares last traded at $63.00, with a volume of 16,296 shares.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded shares of Novozymes A/S from a "strong-buy" rating to a "hold" rating in a report on Monday, August 25th. One research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Buy".

Check Out Our Latest Report on NVZMY

Novozymes A/S Stock Down 1.8%

The company has a quick ratio of 1.07, a current ratio of 1.75 and a debt-to-equity ratio of 0.28. The firm has a market cap of $29.50 billion, a PE ratio of 39.87, a P/E/G ratio of 1.24 and a beta of 0.97. The firm's 50 day moving average is $62.76 and its 200-day moving average is $66.14.

Novozymes A/S Cuts Dividend

The business also recently declared a dividend, which was paid on Thursday, September 11th. Investors of record on Wednesday, September 3rd were given a dividend of $0.1856 per share. The ex-dividend date of this dividend was Tuesday, September 2nd. This represents a yield of 88.0%. Novozymes A/S's dividend payout ratio is 23.42%.

Novozymes A/S Company Profile

(Get Free Report)

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novozymes A/S Right Now?

Before you consider Novozymes A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novozymes A/S wasn't on the list.

While Novozymes A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.